Press "Enter" to skip to content

New patent for Astrazeneca Pharms drug TAGRISSO

0
Copyright © DrugPatentWatch. Originally published at New patent for Astrazeneca Pharms drug TAGRISSO

Annual Drug Patent Expirations for TAGRISSO
Annual Drug Patent Expirations for TAGRISSO

Tagrisso is a drug marketed by Astrazeneca Pharms and is included in one NDA. It is available from one supplier. There are three patents protecting this drug.

This drug has one hundred and twenty-seven patent family members in forty-two countries.

The generic ingredient in TAGRISSO is osimertinib mesylate. One supplier is listed for this compound. Additional details are available on the osimertinib mesylate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Astrazeneca Pharms drug TAGRISSO
    Get the DrugPatentWatch Daily Briefing

    ✓ Patent Expirations and Generic Entry

    ✓ Insightful Articles & Case Studies

    ✓ Patent Litigation & Challenges

    ✓ 505(b)(2) & Biosimilars

    ✓ Industry Trends

    Do NOT follow this link or you will be banned from the site!